Literature DB >> 10707936

Cytokine balance and lipid antigen presentation in the NOD mouse pancreas during development of insulitis.

T Teros1, R Hakala, L Ylinen, A Liukas, P Arvilommi, S Sainio-Pöllänen, E Veräjänkorva, P Pöllänen, O Simell.   

Abstract

The role of cytokine balance and lipid antigen presentation in the development of diabetes was studied using immunohistochemistry of cytokines in the pancreas of non-obese diabetic mice (NOD) and BALB/c mice at various ages. In both the NOD and BALB/c mice, interleukin 10 (IL-10) was expressed in the islets. IL-10 was also present in the epithelial cells of the exocrine tissue in both strains. In the NOD mice, IL-10 disappeared from both the islets and the exocrine tissue at 16 weeks of age. At this age, IL-10 was still present in the islets and exocrine tissue of the BALB/c pancreata. IL-10 was not present in the pancreata of diabetic NOD mice. IL-6 first appeared in the pancreas at 10 weeks of age and disappeared at the age of 16 weeks in both NOD and BALB/c mice. It was present in the endothelial cells. Neither the pancreata of normal BALB/c mice nor NOD mice at 2-16 weeks of age contained tumor necrosis factor alpha (TNF-alpha), interferon gamma (IFN-gamma), IL-4, or IL-12. At 8 weeks of age, a few IL-2+ cells were found in the pancreas of one of three NOD mice. CD1d was already present in both strains at 2 weeks of age but disappeared from the NOD mice at 16 weeks of age. CD1d localized to walls of tubular structures probably representing collecting tubules. These results suggest that in the NOD mice the disappearance of the T(H0), T(H1), and T(H2) responses inhibiting IL-10 from the islets at the age of 16 weeks may trigger the final stage of the immune response leading to overt diabetes. The simultaneous disappearance of CD1d suggests that activation of immune responses against lipid antigens does not play a role in this stage of the disease.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10707936     DOI: 10.1097/00006676-200003000-00013

Source DB:  PubMed          Journal:  Pancreas        ISSN: 0885-3177            Impact factor:   3.327


  6 in total

1.  Protective role of adenovirus vector-mediated interleukin-10 gene therapy on endogenous islet β-cells in recent-onset type 1 diabetes in NOD mice.

Authors:  Cheng Li; Lijuan Zhang; Yanyan Chen; Xiaojie Lin; Tang Li
Journal:  Exp Ther Med       Date:  2016-03-15       Impact factor: 2.447

2.  Autoantigens plus interleukin-10 suppress diabetes autoimmunity.

Authors:  Béla Dénes; István Fodor; William H R Langridge
Journal:  Diabetes Technol Ther       Date:  2010-08       Impact factor: 6.118

3.  Recombinant adenoviral expression of IL-10 protects beta cell from impairment induced by pro-inflammatory cytokine.

Authors:  Ai-Jing Xu; Wei Zhu; Fei Tian; Li-Hua Yan; Tang Li
Journal:  Mol Cell Biochem       Date:  2010-07-25       Impact factor: 3.396

4.  Mesenchymal stem cell transplantation in newly diagnosed type-1 diabetes patients: a phase I/II randomized placebo-controlled clinical trial.

Authors:  Mahmoud Izadi; Anavasadat Sadr Hashemi Nejad; Maedeh Moazenchi; Safdar Masoumi; Ali Rabbani; Farzad Kompani; Amir Abbas Hedayati Asl; Fatemeh Abbasi Kakroodi; Neda Jaroughi; Mohammad Ali Mohseni Meybodi; Aria Setoodeh; Farzaneh Abbasi; Seyedeh Esmat Hosseini; Fatemeh Moeini Nia; Reza Salman Yazdi; Roghayeh Navabi; Ensiyeh Hajizadeh-Saffar; Hossein Baharvand
Journal:  Stem Cell Res Ther       Date:  2022-06-20       Impact factor: 8.079

5.  Type-I Interferons Inhibit Interleukin-10 Signaling and Favor Type 1 Diabetes Development in Nonobese Diabetic Mice.

Authors:  Marcos Iglesias; Anirudh Arun; Maria Chicco; Brandon Lam; C Conover Talbot; Vera Ivanova; W P A Lee; Gerald Brandacher; Giorgio Raimondi
Journal:  Front Immunol       Date:  2018-07-16       Impact factor: 7.561

6.  Subclinical Inflammation and Endothelial Dysfunction in Patients with Chronic Pancreatitis and Newly Diagnosed Pancreatic Cancer.

Authors:  A Gasiorowska; R Talar-Wojnarowska; A Kaczka; A Borkowska; L Czupryniak; E Małecka-Panas
Journal:  Dig Dis Sci       Date:  2015-11-23       Impact factor: 3.199

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.